Chemotherapy in hormone-refractory prostate cancer: Docetaxel with and without VT122.

被引：0
|
作者：
Bhattacharyya, Gouri Shankar
Bascomb, Newell
Malhotra, Hemant
Biswas, Ghanashyam
Bondarde, Shailesh Arjun
机构：
[1] FORTIS Hosp, Kolkata, India
[2] Vicus Therapeut, Morristown, NJ USA
[3] ICON ARO, Jaipur, Rajasthan, India
[4] Sparsh Hosp & Crit Care, Bhubaneswar, India
[5] Shatabdi Super Specialty Hosp, Nasik, India
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16062
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Oral chemotherapy in the treatment of hormone-refractory prostate cancer
    Pienta, KJ
    Kamradt, JM
    Smith, DC
    DRUGS, 1999, 58 (Suppl 3) : 127 - 131
  • [22] Weekly docetaxel in hormone-refractory prostate carcinoma
    Lupo, G.
    Buemi, G. P. B.
    Marabello, G.
    Gnani, A.
    Leone, A.
    Maniaci, V
    Altavilla, G.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI83
  • [23] Chemotherapy with mitoxantrone in hormone-refractory prostate cancer - In reply
    Tannock, I
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 410 - 411
  • [24] Oral Chemotherapy in the Treatment of Hormone-Refractory Prostate Cancer
    Kenneth J. Pienta
    Jeffrey M. Kamradt
    David C. Smith
    Drugs, 1999, 58 : 127 - 131
  • [25] Promising chemotherapy regimen for hormone-refractory prostate cancer
    Tamsin Osborne
    Nature Clinical Practice Urology, 2006, 3 (1): : 8 - 9
  • [26] Taxanes in the chemotherapy of hormone-refractory prostate
    Johannsen, M
    Wilke, K
    Schnorr, D
    Loening, SA
    UROLOGE A, 2004, 43 (02): : 160 - 167
  • [27] Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
    Tsakalozou, Eleftheria
    Eckman, Allison M.
    Bae, Younsoo
    BIOCHEMISTRY RESEARCH INTERNATIONAL, 2012, 2012
  • [28] Weekly docetaxel for advanced hormone-refractory prostate cancer-HRPC
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [29] Docetaxel and zoledronic acid in patients with metastatic hormone-refractory prostate cancer
    Vordos, D
    Paule, B
    Vacherot, F
    Allory, Y
    Salomon, L
    Hoznek, A
    Yiou, R
    Chopin, D
    Abbou, CC
    de la Taille, A
    BJU INTERNATIONAL, 2004, 94 (04) : 524 - 527
  • [30] Weekly docetaxel for advanced hormone-refractory prostate cancer-hrpc
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
12345